anonymous
Guest
anonymous
Guest
Hind sight is 20-20, right, John! Pfizer had to pull back those price increases due to public and investor outrage. This just confirms that Ian and Frank are disconnected from market reality and don't have a clue on how to drive revenue outside of taking price. Big innovative ideas relative to those over inflated salaries of the ELT.